Co-Diagnostics, Inc.
CODXNasdaq
$2.46
↓ -1.0%Jul 17 close · end-of-day
Price
1Y↓ -68.7%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$5.5M
Enterprise Value
-$2.7M
P/E
—
P/S
7.7
P/B
0.3
EV/EBITDA
—
PEG
—
FCF Yield
-522.9%
Dividend Yield
—
Revenue (TTM)
$718,166.00
Net Income (TTM)
-$48.6M
Free Cash Flow (TTM)
-$29.0M
Gross Margin
45.1%
Operating Margin
-7076.6%
Net Margin
-6768.2%
ROE
-303.0%
ROIC
-514.0%
Debt / Equity
—
Net Cash
$8.2M
Return 1Y
-70.2%
Company profile
Co-Diagnostics, Inc. develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and analysis of nucleic acid molecules. Company also provides tests that identify genetic traits in plant and animal genomes. Company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
- CEO
- Dwight H. Egan
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 100
- Headquarters
- Utah
- Website
- codiagnostics.com
Management & directors
- Abbott Richard DavidPresident
- Brown Brian LeeChief Financial Officer
- Egan Dwight HChief Executive Officer
Roles derived from SEC Form 4 filings.
Earnings
CODX Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$145,954.00↑ +190.3%
Diluted EPS-$4.06↓ -42.4%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $74.6M | $97.9M | $34.2M | $6.8M | $3.9M | $622,489.00 |
| Gross profit | $58.0M | $86.3M | $28.7M | $2.6M | $2.9M | $400,112.00 |
| Operating income | $41.7M | $46.1M | -$27.0M | -$42.7M | -$40.1M | -$50.2M |
| Net income | $42.5M | $36.7M | -$14.2M | -$35.3M | -$38.0M | -$47.0M |
| Diluted EPS | $1.52 | $1.23 | -$0.45 | -$1.20 | -$37.22 | -$35.25 |
| Operating cash flow | $28.2M | $41.1M | $6.6M | -$22.1M | -$29.2M | -$29.1M |
| Free cash flow | $27.4M | $40.4M | $5.1M | -$23.4M | -$29.9M | -$29.8M |
| Gross margin | 77.7% | 88.2% | 84.0% | 38.6% | 74.5% | 64.3% |
| Operating margin | 55.9% | 47.1% | -78.8% | -626.9% | -1023.7% | -8058.8% |
| Net margin | 57.0% | 37.5% | -41.6% | -518.7% | -970.6% | -7550.3% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.7M | $641,141.00 | $149,325.00 | $50,277.00 | $162,910.00 | $145,380.00 | $263,922.00 | $145,954.00 |
| Gross profit | $2.4M | $343,738.00 | -$105,743.00 | $28,687.00 | $130,804.00 | $119,095.00 | $121,526.00 | -$47,814.00 |
| Operating income | -$7.7M | -$10.2M | -$11.9M | -$8.6M | -$8.1M | -$7.0M | -$26.5M | -$9.2M |
| Net income | -$7.6M | -$9.7M | -$11.4M | -$7.5M | -$7.7M | -$5.9M | -$25.8M | -$9.1M |
| Diluted EPS | -$0.25 | -$0.32 | -$36.34 | -$7.05 | -$0.23 | -$0.16 | -$27.81 | -$4.06 |
| Operating cash flow | -$5.2M | -$7.2M | -$8.2M | -$8.7M | -$8.3M | -$5.9M | -$6.2M | -$7.8M |
| Free cash flow | -$5.3M | -$7.4M | -$8.3M | -$8.8M | -$8.7M | -$6.0M | -$6.3M | -$8.0M |
| Gross margin | 92.0% | 53.6% | -70.8% | 57.1% | 80.3% | 81.9% | 46.0% | -32.8% |
| Operating margin | -289.1% | -1596.4% | -7973.9% | -17009.7% | -4946.1% | -4824.5% | -10056.7% | -6309.1% |
| Net margin | -286.0% | -1512.4% | -7629.1% | -14983.5% | -4745.0% | -4049.3% | -9794.5% | -6262.3% |
Company news
Jul 16, 2026
Jul 1, 2026
Jun 25, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-23 | Egan Dwight H· Chief Executive Officer | D | 1,633 | $5.07 | $8,279.31 | filing |
| 2026-05-23 | Brown Brian Lee· Chief Financial Officer | D | 1,350 | $5.07 | $6,844.50 | filing |
| 2026-05-23 | Abbott Richard David· President | D | 680 | $5.07 | $3,447.60 | filing |
| 2026-05-23 | Egan Dwight H· Chief Executive Officer | Award | 4,584 | $0.00 | $0.00 | filing |
| 2026-05-23 | Abbott Richard David· President | Award | 1,890 | $0.00 | $0.00 | filing |
| 2026-05-23 | Murphy Edward L. | Award | 1,695 | $0.00 | $0.00 | filing |
| 2026-05-23 | Durenard Eugene | Award | 1,695 | $0.00 | $0.00 | filing |
| 2026-05-23 | NELSON JAMES B | Award | 1,695 | $0.00 | $0.00 | filing |
| 2026-05-23 | Brown Brian Lee· Chief Financial Officer | Award | 3,750 | $0.00 | $0.00 | filing |
| 2026-05-23 | SERBIN RICHARD S | Award | 1,695 | $0.00 | $0.00 | filing |
| 2025-11-23 | Egan Dwight H· Chief Executive Officer | D | 49,575 | $0.35 | $17,351.25 | filing |
| 2025-11-23 | Brown Brian Lee· Chief Financial Officer | D | 40,723 | $0.35 | $14,253.05 | filing |
| 2025-11-23 | Abbott Richard David· President | D | 17,200 | $0.35 | $6,020.00 | filing |
| 2025-11-23 | NELSON JAMES B | Award | 57,499 | $0.00 | $0.00 | filing |
| 2025-11-23 | Murphy Edward L. | Award | 57,499 | $0.00 | $0.00 | filing |
| 2025-11-23 | Brown Brian Lee· Chief Financial Officer | Award | 134,167 | $0.00 | $0.00 | filing |
| 2025-11-23 | Abbott Richard David· President | Award | 56,667 | $0.00 | $0.00 | filing |
| 2025-11-23 | Egan Dwight H· Chief Executive Officer | Award | 163,333 | $0.00 | $0.00 | filing |
| 2025-11-23 | SERBIN RICHARD S | Award | 57,499 | $0.00 | $0.00 | filing |
| 2025-11-23 | Durenard Eugene | Award | 57,499 | $0.00 | $0.00 | filing |
Latest 20 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.